225 related articles for article (PubMed ID: 33854974)
21. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.
Song J; Lee J; Kim J; Jo S; Kim YJ; Baek JE; Kwon ES; Lee KP; Yang S; Kwon KS; Kim DU; Kang TH; Park YY; Chang S; Cho HJ; Kim SC; Koh SS; Kim S
Oncotarget; 2016 Aug; 7(32):51840-51853. PubMed ID: 27322081
[TBL] [Abstract][Full Text] [Related]
22. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
[TBL] [Abstract][Full Text] [Related]
23. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
[TBL] [Abstract][Full Text] [Related]
24. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
Li F; Zhao Y; Wei L; Li S; Liu J
Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
[TBL] [Abstract][Full Text] [Related]
25. Circulating and tumor-infiltrating myeloid-derived suppressor cells in cervical carcinoma patients.
Wu L; Liu H; Guo H; Wu Q; Yu S; Qin Y; Wang G; Wu Q; Zhang R; Wang L; Zhang L; Liu C; Jiao S; Liu T
Oncol Lett; 2018 Jun; 15(6):9507-9515. PubMed ID: 29844835
[TBL] [Abstract][Full Text] [Related]
26. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
[TBL] [Abstract][Full Text] [Related]
27. Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junction.
Sugihara H; Ishimoto T; Yasuda T; Izumi D; Eto K; Sawayama H; Miyake K; Kurashige J; Imamura Y; Hiyoshi Y; Iwatsuki M; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Takamori H; Baba H
Med Oncol; 2015 Jun; 32(6):618. PubMed ID: 25920609
[TBL] [Abstract][Full Text] [Related]
28. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
De Cicco P; Ercolano G; Ianaro A
Front Immunol; 2020; 11():1680. PubMed ID: 32849585
[TBL] [Abstract][Full Text] [Related]
29. Treatment with lentiviral vectors encoding shRNA against interleukin 10 modulates the immunosuppressive activity of murine colon carcinoma-associated myeloid-derived suppressor cells.
Anger-Góra N; Węgierek-Ciura K; Szczygieł A; Mierzejewska J; Pajtasz-Piasecka E; Rossowska J
Oncol Lett; 2021 Aug; 22(2):582. PubMed ID: 34122633
[TBL] [Abstract][Full Text] [Related]
30. Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.
Safarzadeh E; Orangi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2018 Apr; 233(4):3024-3036. PubMed ID: 28661031
[TBL] [Abstract][Full Text] [Related]
31. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.
Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X
Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236
[TBL] [Abstract][Full Text] [Related]
32. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
33. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis.
Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB
Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733
[TBL] [Abstract][Full Text] [Related]
34. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
[TBL] [Abstract][Full Text] [Related]
35. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
[TBL] [Abstract][Full Text] [Related]
36. Targeting polymorphonuclear myeloid-derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy.
Li S; Long X
MedComm (2020); 2024 Jul; 5(7):e602. PubMed ID: 38911064
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.
Xiao P; Wan X; Cui B; Liu Y; Qiu C; Rong J; Zheng M; Song Y; Chen L; He J; Tan Q; Wang X; Shao X; Liu Y; Cao X; Wang Q
Oncoimmunology; 2016; 5(1):e1063772. PubMed ID: 26942079
[TBL] [Abstract][Full Text] [Related]
38. Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression.
Yu J; Li H; Zhang Z; Lin W; Wei X; Shao B
Front Oncol; 2021; 11():647312. PubMed ID: 33816301
[TBL] [Abstract][Full Text] [Related]
39. Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma.
Pang X; Fan HY; Tang YL; Wang SS; Cao MX; Wang HF; Dai LL; Wang K; Yu XH; Wu JB; Tang YJ; Liang XH
PLoS One; 2020; 15(2):e0229089. PubMed ID: 32092078
[TBL] [Abstract][Full Text] [Related]
40. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
Qu P; Wang LZ; Lin PC
Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
